Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurement and Derivatives

v3.7.0.1
Fair Value Measurement and Derivatives
3 Months Ended
Mar. 31, 2017
Fair Value Disclosures [Abstract]  
Fair Value Measurement and Derivatives

NOTE 8 – FAIR VALUE MEASUREMENT AND DERIVATIVES

 

The Company measures fair value in accordance with a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below:

 

  Level 1 Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
     
  Level 2 Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
     
  Level 3 Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

 

All derivatives recognized by the Company are reported as derivative liabilities on the condensed consolidated balance sheets and are adjusted to their fair value at each reporting date. Unrealized gains and losses on derivative instruments are included in change in value of derivative liabilities on the condensed consolidated statement of operations.

 

The following table sets forth the Company’s condensed consolidated financial assets and liabilities measured at fair value by level within the fair value hierarchy at March 31, 2017 and December 31, 2016. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

    Fair value at                    
    March 31, 2017     Level 1     Level 2     Level 3  
Preferred stock embedded conversion feature   $ 42,925     $ -     $ -     $ 42,925  
Anti-dilution provision in common stock warrants included with preferred stock     69,957       -       -       69,957  
Debenture embedded conversion feature     8,213       -       -       8,213  
Anti-dilution provision in common stock warrants included with debentures     25,470       -       -       25,470  
Bridge Notes     1,218,152       -       -       1,218,152  
Total   $ 1,364,717     $ -     $ -     $ 1,364,717  

 

    Fair value at                    
    December 31, 2016     Level 1     Level 2     Level 3  
Preferred stock embedded conversion feature   $ 123,266     $ -     $ -     $ 123,266  
Anti-dilution provision in common stock warrants included with preferred stock     52,904       -       -       52,904  
Debenture embedded conversion feature     25,884       -       -       25,884  
Anti-dilution provision in common stock warrants included with debentures     10,988       -       -       10,988  
Total   $ 213,042     $ -     $ -     $ 213,042  

 

There were no transfers between levels during the three months ended March 31, 2017.

 

As part of the Merger, the Company assumed Debentures that are convertible into shares of common stock, which Anpath issued in July 2014 (see Note 7). The Debentures’ conversion price will be adjusted depending on various circumstances. The conversion options embedded in these instruments contain no explicit limit to the number of shares to be issued upon settlement and as a result are classified as derivative liabilities under ASC 815. Additionally, the Company issued in connection with the Debentures 415,000 warrants to purchase the Company’s common stock. The conversion price will be adjusted depending on various circumstances, and as there is no explicit limit to the number of shares to be issued upon settlement they are classified as derivative liabilities under ASC 815.

 

The terms of the Company’s convertible redeemable preferred stock (the “Preferred Stock”) (see Note 9) include an anti-dilution provision that requires an adjustment in the common stock conversion ratio should subsequent issuances of the Company’s common stock be issued below the instruments’ original conversion price of $0.26 per share, subject to certain defined excluded issuances. In 2015 per modification agreement with the holders, the conversion price was reset to $0.21, and then in March 2017, the conversion price was reset again to $0.15. Accordingly, we bi-furcated the embedded conversion feature, which is shown as a derivative liability recorded at fair value on the condensed consolidated balance sheets.

 

The agreement setting forth the terms of the common stock warrants issued to the holders of the Preferred Stock (see Note 9) also includes an anti-dilution provision that requires a reduction in the warrant’s exercise price, currently $0.50, should the conversion ratio of the Preferred Stock be adjusted due to anti-dilution provisions. Accordingly, the warrants do not qualify for equity classification, and, as a result, the fair value of the derivative is shown as a derivative liability on the condensed consolidated balance sheets.

 

On March 31, 2017, the Company issued $1,218,152 of Convertible Promissory Notes. The Convertible Promissory Notes (the “Notes”) convert at a 50% discount to the post-funding valuation of the Company at the closing of its next offering in the minimum amount of $5,000,000 (the “Equity Offering”). The conversion valuation has a ceiling of $12,000,000, and a “floor” company value of $6,000,000 in the event there is no Equity Offering before the Notes are able to be converted. The fair value of the Bridge Notes was determined using various Monte Carlo simulations.

 

The following table presents a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis that use significant unobservable inputs (Level 3) and the related realized and unrealized gains (losses) recorded in the condensed consolidated statement of operations during the period:

 

    Preferred stock embedded conversion feature     Anti-dilution provision in common stock warrants included with preferred stock     Debenture embedded conversion feature     Anti-dilution provision in common stock warrants included with debentures     Bridge Debentures     Total  
Fair value, December 31, 2016   $ 123,266     $ 52,904     $ 25,884     $ 10,988     $ -     $ 213,042  
Net unrealized (gain)/loss on derivatives     (80,341 )     17,053       (17,671 )     14,482       -       (66,477 )
Issuances of debt     -       -       -       -       1,218,152       1,218,152  
Fair value, March 31, 2017   $ 42,925     $ 69,957     $ 8,213     $ 25,470     $ 1,218,152     $ 1,364,717  

 

The Company’s derivative liabilities are valued by using Black Scholes methods which approximate Monte Carlo Simulation methods. Where possible, the Company verifies the values produced by its pricing models to market prices. Valuation models require a variety of inputs, including contractual terms, market prices, yield curves, credit spreads, measures of volatility and correlations of such inputs. These derivative liabilities do not trade in liquid markets, and as such, model inputs cannot generally be verified and do involve significant management judgment. Such instruments are typically classified within Level 3 of the fair value hierarchy. The following assumptions were used to value the Company’s derivative liabilities at March 31, 2017: dividend yield of -0-%, volatility of 93.68 – 107.80%, risk free rates of 0.76 - 1.50% and an expected term of 0.3 years to 3.8 years.